HOME >> BIOLOGY >> NEWS
Loyola decides to test new blood substitute in trauma patients at the scene of injury

MAYWOOD, Ill. Loyola University Health System plans to test PolyHeme, an investigational oxygen-carrying blood substitute designed to increase survival of critically injured and bleeding trauma patients at the scene of injury, beginning July 1, 2004, as part of a national clinical trial.

Loyola's Institutional Review Board for the Protection of Human Research Subjects (IRB) approved the clinical trial following extensive public education activities. Since February, Loyola has been conducting a number of community outreach efforts, including meetings with community leadership; open forums with members of the public; placing public notices in community newspapers; and distributing flyers in schools, churches, grocery stores and public health centers. Loyola is one of 20 Level I trauma centers participating in the trial nationwide and the only one in Illinois.

"If the blood substitute works the way we hope it will, it could be the first major advance since the introduction of saline, or salt water, to replace volume after blood loss, around the time of World War I," said Dr. Richard L. Gamelli, principal investigator, chair of the Department of Surgery and professor of trauma surgery, Loyola University Chicago Stritch School of Medicine.

The community outreach efforts were necessary in this study because the nature of the potential patients' injuries extreme shock would typically prevent having informed consent. However, consent will be sought whenever possible.

Currently, patients can only receive blood in a hospital and that means a trauma victim may need to wait up to an hour for a transfusion following transport to the hospital and being typed and cross-matched.

"Saline, the current standard of care, helps us restore a patient's blood pressure but does not deliver oxygen, a critical nutrient to prevent organ damage in the brain, heart, lungs, liver and kidneys," Gamelli explained.

"Carrying blood in an am
'"/>

Contact: Stephen Davidow
sdavidow@lumc.edu
708-216-8232
Loyola University Health System
27-May-2004


Page: 1 2 3 4

Related biology news :

1. Familiarity decides if wolf spider loves em or eats em
2. Experimental drug shown to block mutant protein causing blood disease
3. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
4. A probable cause for high blood pressure identified - shows links with diabetes
5. Probing the surface of white blood cells to enhance immune system medicine
6. Streptococcus infects humans by thwarting blood clotting
7. Strep disrupts blood clotting to infect humans
8. Nucleic acid-amplification testing further safeguards nations blood supply
9. Hopkins scientists use blood proteins to detect ovarian cancer
10. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
11. Oxygen sensing in worms may hold key to healthy blood pressure in humans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode ... in accelerated Point of Care Testing solutions (POCT). Check local listings for more info. ... at medical offices and are shipped to labs throughout the country. Results are then ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable ... support testing operations in the fight against the COVID-19 pandemic in Zambia. , ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and ... a great surgery is only the beginning of a successful study, while protecting and ... Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/10/2020)... LORTON, Va. (PRWEB) , ... July 08, 2020 ... ... laboratory testing services and products, announces a significant expansion of laboratory operations through ... robust collection for agencies implementing testing programs. , Bode-CARES provides ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem cell ... million stem cells. Depending on the patient's condition, treatment may be offered IV, intrathecal ... having some form of Alzheimers dementia, and the incidence continues to increase as individuals ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... the launch of a new clinical diagnostics immuno-oncology service, TissueInsight . ... (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and ...
Breaking Biology Technology:
Cached News: